共 303 条
[1]
Castle PE(2021)Cervical cancer prevention and control in women living with human immunodeficiency virus CA-Cancer J Clin 71 505-526
[2]
Einstein MH(1999)Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12-19
[3]
Sahasrabuddhe VV(2018)Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China Gene 647 192-197
[4]
Walboomers JM(2019)Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer Antivir Res 166 56-65
[5]
Jacobs MV(2012)Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer Vaccine 30 F88-F99
[6]
Manos MM(2015)Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect 21 817-826
[7]
Bosch FX(2009)A review of human carcinogens—part B: biological agents Lancet Oncol 10 321-322
[8]
Kummer JA(2015)Human papillomavirus (HPV) testing for secondary prevention of cervical cancer Curr Obstet Gynecol 4 1-12
[9]
Shah KV(2012)Nucleic acid tests for the detection of alpha human papillomaviruses Vaccine 30 F100-F106
[10]
Snijders PJ(2005)Detection of HPV genotypes in cervical lesions by the HPV DNA chip and sequencing Gynecol oncol 98 369-375